Management of Schedule 8 and Restricted Schedule 4 oral liquid medicines
All WA Health staff authorised to obtain, possess or use Schedule 8 and Schedule 4 medicines must comply with storage, recording and other requirements of the Poisons Act 1964 and Poisons Regulations 1965.
Schedule 8 and Restricted Schedule 4 preparations may be targeted for unauthorised use to abuse or divert into illicit activities. Suitable controls to prevent theft, unauthorised use or unaccounted loss must be in place to prevent and deter unauthorised access. This includes the need for reporting of all stock discrepancies and losses.
Oral liquid medicine formulations require individual measurement of each dose and are therefore subject to minor but unavoidable measurement error. They are then acknowledged to present extra challenges when recording and reporting discrepancies of Schedule 8 and Restricted Schedule 4 medicines.
Extra guidance is warranted to ensure adequate practices in the security, storage, measurement, handling and record keeping of Schedule 8 and Restricted Schedule 4 medicine oral liquid formulations.
In addition to legislative requirements, all authorised health practitioners in WA Health must comply with the Management of Schedule 8 and restricted Schedule 4 oral liquid medicines Policy. This Policy represents the minimum requirements for the secure and accountable management of these oral liquid medicines.
Where the risk of loss, theft or misuse is higher or a specific need identified, hospitals and health services may choose to implement additional local controls or policy requirements.
Professor Bryant Stokes
DEPARTMENT OF HEALTH WA